Longitudinal study of the sex-specific neural and behavioural consequences of prenatal cannabinoid exposure
Alba Cáceres Rodríguez
Team Sex differences in developmental vulnerability to neuropsychiatric diseases
Abstract: Prenatal cannabis exposure poses public health challenges, yet gestational cannabidiol (CBD) impacts remain poorly understood compared to Δ^9-tetrahydrocannabinol (THC). This thesis investigates sex-specific consequences of prenatal THC versus CBD in mice from early maternal interactions to adult social dynamics, risk assessment, and prefrontal circuitry. Pregnant C57BL/6J mice received vehicle, THC (3 mg/kg), or CBD (3 mg/kg) from gestational days 5 to 18, with offspring evaluated via behavioral tracking, social monitoring, and electrophysiology.
Findings reveal sexually dimorphic adaptations. Both cannabinoids caused transient pup growth restriction, but CBD-exposed dams uniquely exhibited hyper-reactivity, selectively prioritizing the retrieval of lightest pups. In adulthood, female treated-THC offspring showed acute hyperlocomotion then social avoidance. Both drugs increased repetitive defensive behaviors, with CBD-exposed females showing exaggerated risk assessment. Prefrontal cortex analysis showed abolished endocannabinoid-mediated long-term depression (eCB-LTD) across both sexes. CBD-exposed males exhibited bidirectional plasticity collapse via synaptic saturation. Conversely, CBD-exposed females maintained a homeostatically scaled-up architecture preserving net balance, whereas THC-exposed females manifested a pro-excitatory phenotype due to lost inhibitory control.
Collectively, these data provide a comprehensive neurobiological framework demonstrating that prenatal cannabinoid exposure permanently rewires the adult medial prefrontal cortex, compromising the synaptic flexibility required for adaptive behavioral transitions, risk appraisal, and social group dynamics. This thesis refutes the narrative of CBD as a benign alternative to THC during pregnancy.
Jury
Christophe Porcher, President – INMED, Marseille
Antonia Manduca, Raporteuse – Dpt of Physiology and Pharmacology, Sapienza University of Rome
Sophie Laguesse, Raporteuse – Giga Institute, Université de Liége
Kenneth Mackie, Examinateur – Gill Institute for Neuroscience, Indiana University Bloomintong
Mickael Degoulet, Examinateur – INT, Marseille
Olivier Manzoni, Directeur de thèse – INMED, Marseille
Friday 20 November 2026 at 2.00 pm – INMED conference room